Liquid-Liquid Phase Separation (LLPS) is emerging as a powerful, biologically inspired delivery vehicle for high-throughput screening (HTS), mimicking the compartmentalisation and molecular organisation found in living cells. By concentrating reagents into dynamic, membrane-less droplets, LLPS enhances assay sensitivity, reduces reagent consumption, and improves physiological relevance. This biomimetic approach streamlines multiplexed screening, supports automation, and opens new avenues for targeting disease-related condensates—transforming how molecular interactions are studied and therapeutics discovered.

Functional genomics seeks to decode gene functions and interactions by manipulating gene expression across a range of cell types. BubbleFect advances this field by offering superior transfection efficiency, low cytotoxicity, compatibility with various nucleic acids, and stability at room temperature. These features enable researchers to carry out more reliable, scalable, and high-throughput gene modulation studies—accelerating discoveries in disease mechanisms and therapeutic development.

Molecular condensates—membrane-less compartments formed through phase separation—are emerging as powerful enhancers of CRISPR genome editing. By concentrating CRISPR components, improving specificity, and enabling programmable control, condensates unlock new applications in gene therapy, functional genomics, and synthetic biology. This innovative fusion of technologies offers a pathway to more efficient, targeted, and responsive genome engineering.